Medical Industry Feature

Addressing Questions Regarding Long-Term Treatment with a TPRV1 Agonist for Painful DPN of the Feet


Listen Later

Host: David M. Simpson, MD
Guest: Serge Perrot, MD, PhD

Dive into the data from an international trial evaluating the long-term safety and tolerability of a treatment option for painful diabetic peripheral neuropathy of the feet with Dr. David M. Simpson, a Professor of Neurology at Icahn School of Medicine at Mount Sinai, and Professor Serge Perrot, a Professor of Clinical Pharmacology at Paris Descartes University.

Find the full Prescribing Information here.

QUTENZA® is a registered trademark of Averitas Pharma, Inc.
© 2021 Averitas Pharma, Inc. All rights reserved.
M-QZA-US-01-21-0073 June 2021

...more
View all episodesView all episodes
Download on the App Store

Medical Industry FeatureBy ReachMD

  • 4
  • 4
  • 4
  • 4
  • 4

4

1 ratings


More shows like Medical Industry Feature

View all
SexMed by ReachMD

SexMed

3 Listeners

Partners in Practice by ReachMD

Partners in Practice

3 Listeners

Second Opinion LIVE! by ReachMD

Second Opinion LIVE!

0 Listeners

Medical Breakthroughs from Penn Medicine by ReachMD

Medical Breakthroughs from Penn Medicine

6 Listeners

Advances in Women's Health by ReachMD

Advances in Women's Health

15 Listeners

GI Insights by ReachMD

GI Insights

18 Listeners

Conference Coverage by ReachMD

Conference Coverage

0 Listeners